Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June -
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
- 2018 -
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
June 2018 - 57 products
L
IP
V/S
VaxigripTetra
9.58
26.85
10 %
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
V/S
VaxigripTetra
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
VaxigripTetra
10
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
VaxigripTetra
10
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
CI
Prograf 0.5 mg
60
76.28
98.25
10 %
Capsules: Tacrolimusum
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
IP
Prograf 1 mg
60
112.76
137.35
10 %
Capsules: Tacrolimusum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
IP
Prograf 5 mg
60
511.88
565.50
10 %
Capsules: Tacrolimusum 5 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
IP
Carboplatin Accord 50
mg/5 ml
8.76
25.95
10 %
Infusion solution: Carboplatinum 50mg / 5ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Accord 150
mg/15 ml
26.45
45.15
10 %
Infusion solution: Carboplatinum 150mg / 15ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Accord 450
mg/45 ml
79.34
102.70
10 %
Infusion solution: Carboplatinum 450mg / 45ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Carboplatin Accord 600
mg/60 ml
105.79
131.35
10 %
Infusion solution: Carboplatinum 600mg / 60ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Cisplatin Accord 10 mg/10 ml
14.00
31.65
10 %
Concentrate for infusion: Cisplatinum 10mg / 10ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Cisplatin Accord 25 mg/25 ml
30.80
49.95
10 %
Concentrate for infusion: Cisplatinum 25mg / 25ml
Accord Healthcare AG
A / SL / SG
FB
G
IP
Cisplatin Accord 50 mg/50 ml
56.85
78.30
10 %
Concentrate for infusion: Cisplatinum 50mg / 50ml
Accord Healthcare AG
●
A / SL / SG
FB
G
IP
Cisplatin Accord 100
mg/100 ml
97.70
122.85
10 %
Concentrate for infusion: Cisplatinum 100mg / 100ml
Accord Healthcare AG
●
A / SL / SG
FB
G
L
IP
CI
Co-Valsartan Amlo Spirig HC
5/160/12.5mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Co-Valsartan Amlo Spirig HC
5/160/12.5mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Valsartan Amlo Spirig HC
10/160/12.5mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Valsartan Amlo Spirig HC
10/160/12.5mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
Co-Valsartan Amlo Spirig HC
5/160/25mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Valsartan Amlo Spirig HC
5/160/25mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Valsartan Amlo Spirig HC
10/160/25mg
28
15.58
33.35
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Co-Valsartan Amlo Spirig HC
10/160/25mg
98
54.45
75.65
10 %
Coated tablets: 3 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Ezetimib-Simvastatin-
Mepha Teva 10/10 mg
28
12.62
30.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Ezetimib-Simvastatin-
Mepha Teva 10/10 mg
98
44.04
64.30
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ezetimib-Simvastatin-
Mepha Teva 10/20 mg
28
14.22
31.90
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ezetimib-Simvastatin-
Mepha Teva 10/20 mg
98
49.63
70.40
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ezetimib-Simvastatin-
Mepha Teva 10/40 mg
28
16.56
34.45
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ezetimib-Simvastatin-
Mepha Teva 10/40 mg
100
58.34
79.85
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ezetimib-Simvastatin-
Mepha Teva 10/80 mg
28
20.06
38.25
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Ezetimib-Simvastatin-
Mepha Teva 10/80 mg
100
71.59
94.25
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Dexamethason Galepharm Amp
4mg/1ml
3
6.00
15.75
10 %
Injection solution: Dexamethasoni Dihydrogenophosphas 4 mg
Galepharm AG
B / SL
FB
G
L
IP
Dexamethason Galepharm Amp
4mg/1ml
10
20.00
38.15
10 %
Injection solution: Dexamethasoni Dihydrogenophosphas 4 mg
Galepharm AG
B / SL
FB
G
IP
Dexamethason Galepharm Amp
8mg/2ml
3
10.20
27.50
10 %
Injection solution: Dexamethasoni Dihydrogenophosphas 8 mg
Galepharm AG
B / SL
FB
G
L
IP
Dexamethason Galepharm Amp
8mg/2ml
10
34.00
53.40
10 %
Injection solution: Dexamethasoni Dihydrogenophosphas 8 mg
Galepharm AG
B / SL
FB
G
L
IP
CI
Fasenra 30 mg /1 ml
2319.39
2538.90
10 %
Injection solution in prefilled syringe: Benralizumabum 30 mg/ml
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Tremfya 100 mg/1 ml
2098.96
2299.15
10 %
Injection solution in prefilled syringe: Guselkumabum 100 mg/ml
Janssen-Cilag AG
B / SL
FB
G
L
IP
Imfinzi 120 mg/2.4 ml
509.61
570.65
10 %
Concentrate for infusion: Durvalumabum 120mg / 2.4ml
AstraZeneca AG
A / SL
FB
G
L
IP
Imfinzi 500 mg/10 ml
2123.36
2325.70
10 %
Concentrate for infusion: Durvalumabum 500mg / 10ml
AstraZeneca AG
A / SL
FB
G
L
IP
CI
Ocaliva 5 mg
30
2792.83
3053.80
10 %
Coated tablets: Acidum Obeticholicum 5 mg
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B / SL
FB
G
L
IP
Ocaliva 10 mg
30
2792.83
3053.80
10 %
Coated tablets: Acidum Obeticholicum 10 mg
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B / SL
FB
G
IP
CI
Reagila 1.5 mg
28
88.48
112.65
10 %
Capsules: Cariprazinum 1.5 mg
Recordati AG
B / SL
FB
G
IP
CI
Reagila 1.5 mg
56
155.72
185.75
10 %
Capsules: Cariprazinum 1.5 mg
Recordati AG
B / SL
FB
G
IP
Reagila 3 mg
28
88.48
112.65
10 %
Capsules: Cariprazinum 3 mg
Recordati AG
B / SL
FB
G
IP
Reagila 3 mg
56
155.72
185.75
10 %
Capsules: Cariprazinum 3 mg
Recordati AG
B / SL
FB
G
IP
Reagila 4.5 mg
28
88.48
112.65
10 %
Capsules: Cariprazinum 4.5 mg
Recordati AG
B / SL
FB
G
IP
Reagila 4.5 mg
56
155.72
185.75
10 %
Capsules: Cariprazinum 4.5 mg
Recordati AG
B / SL
FB
G
IP
Reagila 6 mg
28
88.48
112.65
10 %
Capsules: Cariprazinum 6 mg
Recordati AG
B / SL
FB
G
IP
Reagila 6 mg
56
155.72
185.75
10 %
Capsules: Cariprazinum 6 mg
Recordati AG
B / SL
FB
G
L
IP
CI
Benlysta
226.83
263.10
10 %
Lösung zur subkutanen Injektion (Autoinjektor): Belimumabum 200 mg/ml
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Benlysta
4
905.93
1001.65
10 %
Lösung zur subkutanen Injektion (Autoinjektor): Belimumabum 200 mg/ml
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
CM
Saridon neo 400
10
PR
PR
k.A.
Coated tablets: Ibuprofenum 400 mg
Bayer (Schweiz) AG
D
FB
G
IP
CI
Penthrox
3 ml
PR
PR
k.A.
Flüssigkeit zur Herstellung eines Dampfs zur Inhalation: Methoxyfluranum 99.9 % m/m
Future Health Pharma
GmbH
B
FB
G
IP
CI
Penthrox
10 x 3 ml
PR
PR
k.A.
Flüssigkeit zur Herstellung eines Dampfs zur Inhalation: Methoxyfluranum 99.9 % m/m
Future Health Pharma
GmbH
B
FB
G
IP
CI
Penthrox
10 x 3 ml
PR
PR
k.A.
Flüssigkeit zur Herstellung eines Dampfs zur Inhalation: Methoxyfluranum 99.9 % m/m
Future Health Pharma
GmbH
B
FB
G
IP
CI
Acido chenodesossicolico
Leadiant 250 mg
100
PR
PR
k.A.
capsula rigida: Acidum Chenodeoxycholicum 250 mg
CD PHARMA (SUISSE) SA
B
FB
G
IP
Solmucol 20% antidoto
20 ml
PR
PR
k.A.
soluzione per infusione: Acetylcysteinum
IBSA Institut
Biochimique SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
